2C-EF-FLY

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

2C-EF-FLY is a psychedelic drug of the phenethylamine, 2C, and FLY families. It is the FLY (benzodifuran) derivative of 2C-EF and is a fluorinated derivative of 2C-E-FLY. The in-vitro metabolism of 2C-EF-FLY and its monoamine oxidase (MAO) interactions have been described.

2C-EF-FLY produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. It showed around half the potency of 2C-B-FLY and 2C-E-FLY in this assay, but was slightly more potent than 2C-I-FLY. 2C-EF-FLY was first described in the scientific literature by Lea Wagmann and colleagues in 2018 or 2019.

It has been described as a novel designer drug.

2C-EF-FLY is a psychedelic drug of the phenethylamine, 2C, and FLY families. It is the FLY (benzodifuran) derivative of 2C-EF and is a fluorinated derivative of 2C-E-FLY. The in-vitro metabolism of 2C-EF-FLY and its monoamine oxidase (MAO) interactions have been described.

2C-EF-FLY produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. It showed around half the potency of 2C-B-FLY and 2C-E-FLY in this assay, but was slightly more potent than 2C-I-FLY. 2C-EF-FLY was first described in the scientific literature by Lea Wagmann and colleagues in 2018 or 2019.

It has been described as a novel designer drug.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1371211864 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.